<DOC>
	<DOCNO>NCT01435785</DOCNO>
	<brief_summary>Despite wide use propofol target-controlled infusion ( TCI ) elderly patient , pharmacokinetic ( PK ) pharmacodynamic ( PD ) model performance prospectively assessed population . The aim study derive four PKPD model use previously publish PK parameter set , prospectively assess performance elderly people . With obtain data propose build specific PKPD model population .</brief_summary>
	<brief_title>Performance Evaluation Four Pharmacokinetic-Pharmacodynamic ( PKPD ) Models Propofol Elderly Patients</brief_title>
	<detailed_description>After BISÂ® routine monitor place , 14 ASA I-II elderly patient ( &gt; 65 yr ) anesthetize plasma TCI propofol base Schnider model . After partial recovery bolus dose remifentanil infusion start continue throughout surgery . All BIS TCI data continuously record . Arterial blood sample propofol assay collect 1 , 2 , 3 , 5 , 10 , 20 , 40 60 min post-induction , 0 , 1 , 3 , 5 , 10 min stop infusion . A three compartment effect site model link Sigmoidal Emax PD model , use fit data simultaneously NONMEM . Median performance error ( MDPE ) , median absolute performance error ( MDAPE ) calculate measure bias accuracy model . Comparisons model perform .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<criteria>Patients older 65 year , ASA 1,2 Included le 70 % 130 % ideal body weight Neurologic disorder Use psychoactive medication , include alcohol intake last 48 hour</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>PKPD</keyword>
	<keyword>Propofol</keyword>
	<keyword>TCI</keyword>
	<keyword>Elderly patient</keyword>
</DOC>